Sabra Health Care REIT

Q3 2025 +2.35%Q2 2025 -1.47%Q1 2025 +1.18%Q4 2024 -0.97%Q3 2024 -4.80%Q2 2024 -0.12%Q1 2024 -1.70%Q4 2023 +0.43%Q3 2023 +0.72%Q2 2023 +0.78%Q1 2023 -0.54%Q4 2022 -4.22%Q3 2022 -13.13%Q2 2022 0.00%Q1 2022 +10.36%Q4 2021 -3.92%Q3 2021 -2.11%Q2 2021 -3.73%Q1 2021 -2.19%Q4 2020 +1.73%Q3 2020 -3.99%Q2 2020 +4.42%Q1 2020 -5.72%Q4 2019 -3.50%Q3 2019 +3.32%Q2 2019 +5.54%Q1 2019 -1.58%Q4 2018 -2.66%Q3 2018 -0.56%Q2 2018 -0.31%Q1 2018 +3.34%Q4 2017 +2.77%Q3 2017 -1.51%Q2 2017 +1.64%Q1 2017 -10.19%Q4 2016 +0.58%Q3 2016 -8.90%Q2 2016 +1.63%Q1 2016 +4.36%Q4 2015 +8.32%Q3 2015 -2.85%Q2 2015 -4.59%Q1 2015 -6.02%Q4 2014 -0.92%Q3 2014 -0.95%Q2 2014 -2.02%Q1 2014 -2.63%Q4 2013 +0.82%Q3 2013 +4.13%Q2 2013 -7.25%Q1 2013 +2.38%Q4 2012 +0.04%Q3 2012 +2.63%Q2 2012 +3.01%Q1 2011 -4.56%Q1 2012 +2.43%Q4 2011 +5.09%Q3 2011 +7.50%Q2 2011 +3.86%Q4 2010 -6.51%

Feb 21, 2023

•

Dec 31, 2022

Sabra Health Care REIT Q4 2022 Earnings Report

Sabra Health Care REIT's financial performance for Q4 2022 was reported, showing a net loss but positive FFO, Normalized FFO, and AFFO.

Key Takeaways

Sabra Health Care REIT reported a net loss of $(0.37) per diluted common share for Q4 2022. However, the company's FFO was $0.25, Normalized FFO was $0.37, and AFFO was $0.34. The transition of the 24-property portfolio to Ensign Group and Avamere was completed, and the company made strategic investments and dispositions during the quarter.

Net loss per diluted common share was $(0.37).

FFO was $0.25 per diluted common share.

Normalized FFO was $0.37 per diluted common share.

AFFO was $0.34 per diluted common share.